A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation

Clinical trial NCT00455013 · COMPLETED

Trial details

NCT number: NCT00455013
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Disorder Related to Renal Transplantation

Start date: 2007-07-01
Primary completion: 2008-10-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.